7539-61-9

Usage

Uses

Used in Pharmaceutical Industry:
3-(dipropan-2-ylamino)propan-1-ol is used as a pharmaceutical intermediate for the production of drugs such as propranolol, a crucial beta-blocker utilized in the treatment of high blood pressure, angina, and other cardiovascular conditions.
Used in Organic Synthesis:
In the realm of organic synthesis, 3-(dipropan-2-ylamino)propan-1-ol serves as a reactant for the preparation of other complex compounds, contributing to the development of novel chemical entities and materials.
Safety and Handling:
This chemical should be handled and stored according to standard laboratory procedures, and caution is advised due to its potential health hazards if mismanaged.

Upstream product

• 503-30-0 trimethylene oxide 
• 693-03-8 n-butyl magnesium bromide 
• 60-29-7 diethyl ether 
• 108-18-9 diisopropylamine 
• 627-30-5 1-chloro-3-hydroxypropane 
• 627-18-9 1-bromo-3-propanol 

Downstream Products

• 866723-79-7 diisopropyl-(3-phenylphosphinoyl-propyl)-amine 
• 866723-78-6 (3-diisopropylamino-propyl)-phenyl-phosphinic acid ethyl ester 
• 866723-72-0 [3-(aminomethyl-phenyl-phosphinoyl)-propyl]-diisopropyl-amine 
• 866723-81-1 2-[(3-diisopropylamino-propyl)-phenyl-phosphinoylmethyl]-isoindole-1,3-dione 

Relevant academic research and scientific papers

A versatile and recyclable molecularly imprinted polymer as an oxidative catalyst of sulfur derivatives: A new possible method for mustard gas and v nerve agent decontamination

A molecularly imprinted polymer containing a porphyrin unit was developed as a biomimetic heterogenous catalyst for the oxidation of sulfur derivatives. Its catalytic efficiency under mild conditions and its easy recovery represent a great asset for the design of new decontamination tools for yperite and VX.

Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity

Diesters of carbonic acid disubstituted with primary, secondary or tertiary amine groups, pharmaceutically acceptable salts thereof, and their use as antiviral and inti-inflammatory agents.

Mild LIBF4-Promoted Aminolysis of Oxetanes

LiBF4 in acetonitrile efficiently catalyzes the aminolysis of trimethylene oxide and 2-octyl oxetane under mild conditions (r.t. or 80 deg C) to give the corresponding γ-amino alcohols in very good yields.

Compounds for the treatment of urinary incontinence

The invention concerns compounds having the formula I STR1 wherein Ar is a phenyl or benzyl group which is optionally substituted with hydroxy or alkoxy;R 1 is hydrogen, lower alkyl, lower alkoxy, hydroxy;R 2 is hydrogen, lower alkyl;R 3 is NR 4 R 5, whereinR 4 and R 5 which can be the same or different, are lower alkyl, or wherein R 4 and R 5, when taken together, form a ring with the nitrogen atom, whereby said ring optionally is substituted with lower alkyl;n is 0 or 1;m is 2 or 3 andtheir salts with physiologically acceptable acids and when the compounds can be in form of optical isomers, the racemic mixture and the individual isomers, for the treatment of disorders of the urinary bladder.

Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal antiinflammatory drugs

Quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal anti-inflammatory drugs (NSAIDs) are disclosed. These esters and thioesters display the anti--inflammatory profile of the parent NSAIDs with greatly reduced gastrointestinal irritancy, providing a more favorable separation of therapeutic activity and toxicological side effects than the parent NSAIDs.